PharmaShots | Incisive News in 3 Shots

Subscribe Now

Rare Blood Vessel Disorders

Roche's Rituxan (rituximab) Receives the US FDA's Approval for Two Rare Blood Vessel Disorders in Pediatric Patients Aged 2yrs. and Above

Roche's Rituxan (rituximab) Receives the US FDA's Approval for Two Rare Blood Vessel Disorders in Pediatric Patients Aged 2yrs. an...

September 30, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us